STOCK TITAN

Clarivate Repeats Success in Nobel Prize Predictions with Eight New Winners Identified by Citation Laureates Program

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags

Clarivate Plc (NYSE:CLVT) has announced the success of its annual Citation Laureates™ program, accurately predicting eight Nobel Prize 2024 recipients. The program, powered by the Web of Science Core Collection™ citation index, combines citation analysis with expert insights to identify potential Nobel laureates. Since 2002, 83 out of 441 Citation Laureates have received a Nobel Prize, with successful forecasts every year since 2007.

Notable predictions include David Baker, Demis Hassabis, and John M. Jumper for the Nobel in Chemistry, Victor Ambros and Gary Ruvkun for Physiology or Medicine, and Daron Acemoglu, Simon Johnson, and James A. Robinson for Economic Sciences. The success of the program highlights the value of Clarivate's data-driven approach in identifying researchers with exceptional citation records and potential Nobel honors.

Clarivate Plc (NYSE:CLVT) ha annunciato il successo del suo programma annuale Citation Laureates™, predicendo con precisione otto destinatari del Premio Nobel 2024. Il programma, supportato dall'indice di citazione Web of Science Core Collection™, combina l'analisi delle citazioni con le intuizioni di esperti per identificare potenziali premi Nobel. Dal 2002, 83 su 441 Citation Laureates hanno ricevuto un Premio Nobel, con previsioni corrette ogni anno dal 2007.

Le previsioni notevoli includono David Baker, Demis Hassabis e John M. Jumper per il Nobel in Chimica, Victor Ambros e Gary Ruvkun per la Fisiologia o la Medicina, e Daron Acemoglu, Simon Johnson e James A. Robinson per le Scienze Economiche. Il successo del programma evidenzia il valore dell'approccio basato sui dati di Clarivate nell'identificare ricercatori con eccezionali record di citazione e potenziali onorificenze Nobel.

Clarivate Plc (NYSE:CLVT) ha anunciado el éxito de su programa anual Citation Laureates™, prediciendo con precisión ocho receptores del Premio Nobel 2024. El programa, respaldado por el índice de citas del Web of Science Core Collection™, combina el análisis de citas con la experiencia de expertos para identificar posibles laureados del Nobel. Desde 2002, 83 de 441 Citation Laureates han recibido un Premio Nobel, con pronósticos exitosos cada año desde 2007.

Las predicciones notables incluyen a David Baker, Demis Hassabis y John M. Jumper para el Nobel en Química, Victor Ambros y Gary Ruvkun para Fisiología o Medicina, y Daron Acemoglu, Simon Johnson y James A. Robinson para Ciencias Económicas. El éxito del programa destaca el valor del enfoque basado en datos de Clarivate para identificar investigadores con registros de citas excepcionales y posibles honores Nobel.

Clarivate Plc (NYSE:CLVT)는 자사의 연례 Citation Laureates™ 프로그램의 성공을 발표하며 2024년 노벨상 수상자 8명을 정확하게 예측했습니다. 이 프로그램은 Web of Science Core Collection™ 인용 지수를 활용하여 인용 분석과 전문가 통찰력을 결합하여 잠재적인 노벨 수상자를 파악합니다. 2002년 이후로 441명의 Citation Laureates 중 83명이 노벨상을 수상했습니다, 2007년 이후 매년 성공적인 예측을 하고 있습니다.

주목할 만한 예측으로는 David Baker, Demis Hassabis, John M. Jumper가 화학 부문 노벨상, Victor Ambros, Gary Ruvkun이 생리학 또는 의학 부문, Daron Acemoglu, Simon Johnson, James A. Robinson이 경제학 부문에 노벨상을 수상할 것으로 예상됩니다. 이 프로그램의 성공은 탁월한 인용 기록과 잠재적인 노벨상을 가진 연구자를 식별하는 데 있어 Clarivate의 데이터 기반 접근 방식의 가치를 강조합니다.

Clarivate Plc (NYSE:CLVT) a annoncé le succès de son programme annuel Citation Laureates™, prédisant avec précision huit lauréats du Prix Nobel 2024. Le programme, propulsé par l'indice de citation Web of Science Core Collection™, combine analyse des citations et expertises pour identifier de potentiels lauréats du Nobel. Depuis 2002, 83 des 441 Citation Laureates ont reçu un Prix Nobel, avec des prévisions réussies chaque année depuis 2007.

Les prévisions notables incluent David Baker, Demis Hassabis et John M. Jumper pour le Nobel de Chimie, Victor Ambros et Gary Ruvkun pour la Physiologie ou la Médecine, et Daron Acemoglu, Simon Johnson et James A. Robinson pour les Sciences Économiques. Le succès du programme souligne la valeur de l'approche basée sur les données de Clarivate pour identifier les chercheurs ayant des antécédents de citation exceptionnels et des honneurs potentiels du Nobel.

Clarivate Plc (NYSE:CLVT) hat den Erfolg seines jährlichen Programms Citation Laureates™ bekannt gegeben und dabei acht Nobelpreisträger 2024 genau vorhergesagt. Das Programm, unterstützt durch den Zitationsindex der Web of Science Core Collection™, kombiniert Zitationsanalysen mit Experteneinsichten, um potenzielle Nobelpreisträger zu identifizieren. Seit 2002 haben 83 von 441 Citation Laureates einen Nobelpreis erhalten, mit erfolgreichen Vorhersagen jedes Jahr seit 2007.

Bemerkenswerte Vorhersagen umfassen David Baker, Demis Hassabis und John M. Jumper für den Nobelpreis in Chemie, Victor Ambros und Gary Ruvkun für Physiologie oder Medizin und Daron Acemoglu, Simon Johnson und James A. Robinson für Wirtschaftswissenschaften. Der Erfolg des Programms hebt den Wert des datengestützten Ansatzes von Clarivate hervor, der ausgezeichnete Zitationsrekorde und potenzielle Nobel-Ehrungen identifiziert.

Positive
  • Accurately predicted 8 Nobel Prize 2024 recipients
  • 83 out of 441 Citation Laureates have received a Nobel Prize since 2002
  • Successful forecasts every year since 2007
  • Demonstrates reliability and value of Clarivate's data-driven approach
Negative
  • None.

83 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002

LONDON, Oct. 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the success of its annual Citation Laureates™ program, following the accurate forecast of eight Nobel Prize 2024 recipients.

Powered by trusted, high-quality data from the Web of Science Core Collection™ citation index, the Citation Laureates program combines rigorous citation analysis with expert qualitative insights to pinpoint researchers with exceptional citation records who have the potential to receive Nobel honors. This ability to forecast Nobel success – whether years in advance or just months before the official announcements – underscores the reliability and value of this data-driven approach.

Since 2002, the Institute for Scientific Information (ISI)™ at Clarivate has identified 441 researchers as Citation Laureates, with 83 later receiving a Nobel Prize. It has successfully forecast recipients every year since 2007.

David Baker, Demis Hassabis and John M. Jumper were named as Citation Laureates this year, just weeks before their Nobel in Chemistry. Physiology or Medicine Nobelists Victor Ambros and Gary Ruvkun were first recognized as Citation Laureates 16 years ago, in 2008. The prize in Economic Sciences, awarded to Daron Acemoglu, Simon Johnson and James A. Robinson was forecast in 2022.

David Pendlebury, Head of Research Analysis, ISI, Clarivate, said: "The Nobel committees' choices for both Physics and Chemistry can only be described as bold. The acknowledgment of the transformational role of AI in research in the two categories, back-to-back, is unprecedented. In Chemistry, we quickly saw something extremely unusual with the key AlphaFold paper from Hassabis and Jumper of DeepMind. Published just three years ago, in 2021, it swiftly amassed more than 16,000 citations in the Web of Science Core Collection. This phenomenally high number is statistically unusual and was achieved so quickly, we could not ignore its influence."

Dr. Nandita Quaderi, Senior Vice President & Editor-in-Chief, Web of Science, Clarivate, said: "Accurately predicting Nobel laureates is challenging. Our ISI analysts have combined their deep bibliometric expertise with more recent AI approaches to develop a proprietary methodology to identify researchers 'of Nobel class'. These individuals are responsible for producing the research that has the greatest societal impact and will help shape the future by solving the world's most pressing and complex challenges."

The eight Citation Laureates named as Nobel laureates in 2024 are:

Victor Ambros and Gary Ruvkun: Nobel Prize in Physiology or Medicine for their discovery of microRNA and its role in post-transcriptional gene regulation, named Citation Laureates in 2008. Ambros and Ruvkun's pioneering research on microRNAs dates back to 1993, and Ambros's key paper is cited nearly 10,000 times – an occurrence so rare that only 500 publications out of 61 million we have indexed since 1970 are cited at this level. The field they helped establish has expanded dramatically from a handful of papers 20 years ago to around 16,000 per year in 2020.

David Baker, Demis Hassabis and John M. Jumper: Nobel Prize in Chemistry for their research into protein structure prediction and computational protein design respectively, identified by ISI In September 2024. Hassabis and Jumper's 2021 paper has already received more than 16,000 citations – a remarkable number that reflects the revolutionary impact of this work.

Daron Acemoglu, Simon Johnson and James A. Robinson: The Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel for studies of how institutions are formed and affect prosperity, named Citation Laureates in 2022. The ISI identified all three using publication and citation analysis – their co-authored 2001 paper has received more than 5,000 citations, which ranks it among the top 10 papers in economics indexed in the Web of Science since 2000.

Notes to editors:

  • Analysts at the ISI name Citation Laureates aligned to the four Nobel categories of Physiology or Medicine, Physics, Chemistry and Economic Sciences. In 2011, 2013 and 2021, the ISI accurately predicted Nobel laureates in all four fields of research.
  • Since 2007, the ISI at Clarivate has successfully forecast researchers who have been the recipients of Nobel Prizes every single year.
  • Learn more about the Hall of Citation Laureates and watch our video interviews with David Baker, John M. Jumper, Daron Acemoglu and James A. Robison.
  • David Pendlebury, Head of Research Analysis at the Institute for Scientific Information at Clarivate is available for interviews.

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

Media contact:
Rebecca Krahenbuhl, Senior Manager, External Communications
newsroom@clarivate.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-repeats-success-in-nobel-prize-predictions-with-eight-new-winners-identified-by-citation-laureates-program-302276071.html

SOURCE Clarivate Plc

FAQ

How many Citation Laureates named by Clarivate have received a Nobel Prize since 2002?

83 Citation Laureates named by Clarivate's Institute for Scientific Information have received a Nobel Prize since 2002.

Who were the Citation Laureates named for the 2024 Nobel Prize in Chemistry?

David Baker, Demis Hassabis, and John M. Jumper were named as Citation Laureates for the 2024 Nobel Prize in Chemistry.

How does Clarivate's Citation Laureates program predict Nobel Prize winners?

Clarivate's Citation Laureates program combines rigorous citation analysis from the Web of Science Core Collection with expert qualitative insights to identify researchers with exceptional citation records who have the potential to receive Nobel honors.

What is the stock symbol for Clarivate?

Clarivate's stock symbol is CLVT, listed on the New York Stock Exchange (NYSE).

Clarivate Plc

NYSE:CLVT

CLVT Rankings

CLVT Latest News

CLVT Stock Data

3.54B
389.32M
15.85%
92.75%
5.06%
Information Technology Services
Services-computer Processing & Data Preparation
Link
United States of America
ST. HELIER